Latest Breaking News On - Solara active pharma sciences ltd - Page 1 : comparemela.com

Solara Active Pharma meets USFDA's inspection at its Visakhapatnam facility

Solara Active Pharma Sciences Ltd's Visakhapatnam facility receives positive USFDA inspection with zero observations, ensuring compliance and quality.

US FDA inspects Vishakhapatnam facility of Solara Active Pharma

US Food and Drug Administration US FDA has successfully completed the inspection of the multipurpose API manufacturing facility of Solara Active Pharma Scienc

Solara Active Pharma: US FDA inspects Vishakhapatnam facility of Solara Active Pharma

The US Food and Drug Administration (FDA) completes inspection of Solara Active Pharma Sciences API manufacturing facility in Visakhapatnam, Andhra Pradesh, with no observations. Solara confirms compliance with FDA standards. The facility, dedicated to Ibuprofen API production, marks Solara s second successful FDA inspection. The company aims for global market expansion with FDA-approved facilities.

Share Market Highlights 28 March 2024: Indian equity markets end FY24 on a bullish note; Sensex jumps 650 pts, Nifty settles above 22,300

When shareholder voting is on, many directors pull their candidature

Most of these opt-outs have happened at firms plagued with governance issues